Francis W. Sarena
2018
Compensation breakdown
| Non-Equity Incentive Plan | $186,110 |
|---|---|
| Option Awards | $536,742 |
| Salary | $448,745 |
| Stock Awards | $130,830 |
| Other | $6,072 |
| Total | $1,308,499 |
Sarena received $536.7K in option awards, accounting for 41% of the total pay in 2018.
Sarena also received $186.1K in non-equity incentive plan, $448.7K in salary, $130.8K in stock awards and $6.1K in other compensation.
Rankings
In 2018, Francis W. Sarena's compensation ranked 7,846th out of 14,244 executives tracked by ExecPay. In other words, Sarena earned more than 44.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,846 out of 14,244 | 45th |
Division Manufacturing | 3,062 out of 5,765 | 47th |
Major group Chemicals And Allied Products | 1,147 out of 2,128 | 46th |
Industry group Drugs | 966 out of 1,817 | 47th |
Industry Pharmaceutical Preparations | 751 out of 1,391 | 46th |
Pay ratio
| Francis W. Sarena's Pay | $1,308,499 |
|---|---|
| Median Employee's Pay | $201,670 |
| Pay Ratio | 6to 1 |
In 2018, the annual total compensation of Francis W. Sarena was $1,308,499.
The annual total compensation of the median employee at Five Prime Therapeutics was $201,670.
The ratio of Francis W. Sarena's pay to the pay of median employee was therefore 6 to one.
Sarena's colleagues
We found six more compensation records of executives who worked with Francis W. Sarena at Five Prime Therapeutics in 2018.
2018
Aron Knickerbocker
Five Prime Therapeutics
Chief Executive Officer
2018
David Smith
Five Prime Therapeutics
Chief Financial Officer
2018
Bryan Irving
Five Prime Therapeutics
Chief Scientific Officer
2018
Helen Collins
Five Prime Therapeutics
Chief Medical Officer
2018
Linda Rubinstein
Five Prime Therapeutics
Chief Financial Officer
2018
Marc Belsky
Five Prime Therapeutics